FRESENIUS SE & CO KGAA (FRE.DE) Fundamental Analysis & Valuation

FRA:FRE • DE0005785604

Current stock price

40.44 EUR
-0.35 (-0.86%)
Last:

This FRE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FRE.DE Profitability Analysis

1.1 Basic Checks

  • FRE had positive earnings in the past year.
  • FRE had a positive operating cash flow in the past year.
  • FRE had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years FRE had a positive operating cash flow.
FRE.DE Yearly Net Income VS EBIT VS OCF VS FCFFRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • FRE has a better Return On Assets (3.05%) than 70.37% of its industry peers.
  • FRE has a Return On Equity (6.62%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 4.90%, FRE perfoms like the industry average, outperforming 48.15% of the companies in the same industry.
Industry RankSector Rank
ROA 3.05%
ROE 6.62%
ROIC 4.9%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRE.DE Yearly ROA, ROE, ROICFRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • With an excellent Profit Margin value of 5.53%, FRE belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • FRE's Profit Margin has improved in the last couple of years.
  • FRE has a better Operating Margin (10.10%) than 88.89% of its industry peers.
  • FRE's Operating Margin has declined in the last couple of years.
  • FRE's Gross Margin of 24.89% is in line compared to the rest of the industry. FRE outperforms 48.15% of its industry peers.
  • FRE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.1%
PM (TTM) 5.53%
GM 24.89%
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
FRE.DE Yearly Profit, Operating, Gross MarginsFRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FRE.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRE is destroying value.
  • There is no outstanding debt for FRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FRE.DE Yearly Shares OutstandingFRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
FRE.DE Yearly Total Debt VS Total AssetsFRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • FRE has an Altman-Z score of 2.08. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of FRE (2.08) is better than 70.37% of its industry peers.
  • FRE has a debt to FCF ratio of 10.99. This is a negative value and a sign of low solvency as FRE would need 10.99 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 10.99, FRE perfoms like the industry average, outperforming 51.85% of the companies in the same industry.
  • A Debt/Equity ratio of 0.57 indicates that FRE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, FRE belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 10.99
Altman-Z 2.08
ROIC/WACC0.73
WACC6.73%
FRE.DE Yearly LT Debt VS Equity VS FCFFRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that FRE should not have too much problems paying its short term obligations.
  • FRE's Current ratio of 1.32 is fine compared to the rest of the industry. FRE outperforms 66.67% of its industry peers.
  • FRE has a Quick Ratio of 1.00. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.00, FRE is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1
FRE.DE Yearly Current Assets VS Current LiabilitesFRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. FRE.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.31% over the past year.
  • The Earnings Per Share has been decreasing by -0.06% on average over the past years.
  • Looking at the last year, FRE shows a small growth in Revenue. The Revenue has grown by 4.76% in the last year.
  • Measured over the past years, FRE shows a decrease in Revenue. The Revenue has been decreasing by -8.81% on average per year.
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.53% on average over the next years. This is quite good.
  • Based on estimates for the next years, FRE will show a small growth in Revenue. The Revenue will grow by 5.44% on average per year.
EPS Next Y15.7%
EPS Next 2Y12.8%
EPS Next 3Y11.2%
EPS Next 5Y10.53%
Revenue Next Year5.05%
Revenue Next 2Y4.97%
Revenue Next 3Y4.97%
Revenue Next 5Y5.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FRE.DE Yearly Revenue VS EstimatesFRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
FRE.DE Yearly EPS VS EstimatesFRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. FRE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.64, the valuation of FRE can be described as correct.
  • FRE's Price/Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 77.78% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.91. FRE is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 10.92, the valuation of FRE can be described as reasonable.
  • FRE's Price/Forward Earnings ratio is rather cheap when compared to the industry. FRE is cheaper than 81.48% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. FRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.64
Fwd PE 10.92
FRE.DE Price Earnings VS Forward Price EarningsFRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRE is on the same level as its industry peers.
  • FRE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.15
EV/EBITDA 8.87
FRE.DE Per share dataFRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • FRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y12.8%
EPS Next 3Y11.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. FRE.DE Dividend Analysis

5.1 Amount

  • FRE has a Yearly Dividend Yield of 2.58%. Purely for dividend investing, there may be better candidates out there.
  • FRE's Dividend Yield is a higher than the industry average which is at 1.64.
  • Compared to an average S&P500 Dividend Yield of 1.82, FRE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.58%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
FRE.DE Yearly Dividends per shareFRE.DE Yearly Dividends per shareYearly Dividends per share 2016 2019 2020 2021 2022 2023 2025 2026 0.5 1 1.5

5.3 Sustainability

  • FRE pays out 54.11% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP54.11%
EPS Next 2Y12.8%
EPS Next 3Y11.2%
FRE.DE Yearly Income VS Free CF VS DividendFRE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B
FRE.DE Dividend Payout.FRE.DE Dividend Payout, showing the Payout Ratio.FRE.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FRE.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS SE & CO KGAA

FRA:FRE (4/29/2026, 4:03:51 PM)

40.44

-0.35 (-0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength12.84
Industry Growth80.67
Earnings (Last)02-25
Earnings (Next)05-06
Inst Owners45.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.78B
Revenue(TTM)22.87B
Net Income(TTM)1.26B
Analysts85.22
Price Target57.32 (41.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.58%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP54.11%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.66%
Min EPS beat(2)-28.85%
Max EPS beat(2)13.53%
EPS beat(4)3
Avg EPS beat(4)2.8%
Min EPS beat(4)-28.85%
Max EPS beat(4)17.61%
EPS beat(8)5
Avg EPS beat(8)2.89%
EPS beat(12)7
Avg EPS beat(12)-36.01%
EPS beat(16)8
Avg EPS beat(16)-32.65%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-4.68%
Max Revenue beat(2)-1.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-4.68%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-0.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.46%
Revenue beat(16)6
Avg Revenue beat(16)-0.35%
PT rev (1m)1.68%
PT rev (3m)2.44%
EPS NQ rev (1m)-1.57%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-3.22%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 12.64
Fwd PE 10.92
P/S 1
P/FCF 21.15
P/OCF 8.85
P/B 1.19
P/tB 9.54
EV/EBITDA 8.87
EPS(TTM)3.2
EY7.91%
EPS(NY)3.7
Fwd EY9.16%
FCF(TTM)1.91
FCFY4.73%
OCF(TTM)4.57
OCFY11.3%
SpS40.61
BVpS33.92
TBVpS4.24
PEG (NY)0.8
PEG (5Y)N/A
Graham Number49.4176 (22.2%)
Profitability
Industry RankSector Rank
ROA 3.05%
ROE 6.62%
ROCE 7%
ROIC 4.9%
ROICexc 5.22%
ROICexgc 11.15%
OM 10.1%
PM (TTM) 5.53%
GM 24.89%
FCFM 4.71%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.78%
OM growth 5Y-3.42%
PM growth 3Y-4.64%
PM growth 5Y3.27%
GM growth 3Y-0.27%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 10.99
Debt/EBITDA 3.17
Cap/Depr 133.66%
Cap/Sales 6.54%
Interest Coverage 6.28
Cash Conversion 75.04%
Profit Quality 85.21%
Current Ratio 1.32
Quick Ratio 1
Altman-Z 2.08
F-Score7
WACC6.73%
ROIC/WACC0.73
Cap/Depr(3y)103.18%
Cap/Depr(5y)90.15%
Cap/Sales(3y)5.87%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y9.46%
EPS 5Y-0.06%
EPS Q2Q%-25%
EPS Next Y15.7%
EPS Next 2Y12.8%
EPS Next 3Y11.2%
EPS Next 5Y10.53%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y2.03%
Revenue growth 5Y-8.81%
Sales Q2Q%5.88%
Revenue Next Year5.05%
Revenue Next 2Y4.97%
Revenue Next 3Y4.97%
Revenue Next 5Y5.44%
EBIT growth 1Y29.27%
EBIT growth 3Y7.94%
EBIT growth 5Y-11.93%
EBIT Next Year52.22%
EBIT Next 3Y20.31%
EBIT Next 5Y13.91%
FCF growth 1Y-23.73%
FCF growth 3Y-22.13%
FCF growth 5Y-23.62%
OCF growth 1Y6.58%
OCF growth 3Y-15.04%
OCF growth 5Y-17.04%

FRESENIUS SE & CO KGAA / FRE.DE Fundamental Analysis FAQ

What is the fundamental rating for FRE stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRE.DE.


What is the valuation status for FRE stock?

ChartMill assigns a valuation rating of 5 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Fairly Valued.


What is the profitability of FRE stock?

FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.


What is the valuation of FRESENIUS SE & CO KGAA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS SE & CO KGAA (FRE.DE) is 12.64 and the Price/Book (PB) ratio is 1.19.


How financially healthy is FRESENIUS SE & CO KGAA?

The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 5 / 10.